HOME > TOP STORIES

TOP STORIES

REGULATORY LDP Lawmakers Not So Positive about Reflecting Societal Values to Drug Prices; They Don’t Know How

March 22, 2019
BUSINESS Biogen/Eisai’s Aducanumab Fails, Dashing Hopes in Alzheimer’s Field

March 22, 2019
BUSINESS Gilead Set to Duplicate Biktarvy Success in Japan with New Stand-Alone HIV Sales Force

March 20, 2019
BUSINESS Employee Sues Bayer Japan for Emotional Distress over Xarelto Scandal

March 19, 2019
ORGANIZATION Kenporen Director Kono: Apply CEA to Reimbursement Decisions Once Credible System Established

March 18, 2019
BUSINESS Drug Makers, Wholesalers Establishing Supervisory Divisions as Detailing Guidelines Rollout Nears

March 15, 2019
REGULATORY MHLW to Promote Master Protocol Trials to Boost Efficiency in New Drug Development

March 14, 2019
BUSINESS Fujifilm Going Full Throttle in CDMO Biz with Buyout of Biogen Unit

March 13, 2019
REGULATORY Detailing Guidelines Casting Clouds over Drug Maker-Sponsored Press Seminars?

March 12, 2019
BUSINESS Meiji Pharma Pursuing Low-Cost Strategy to Weather Storm in Generics Space, Overseas Plants Hold Key

March 11, 2019
BUSINESS Eisai CEO Says “20% ROE in 2025” within Reach If All 3 Alzheimer’s Candidates, Lenvima Deliver

March 8, 2019
INTERVIEW JMA Exec Matsumoto: CEA Scheme Merely a Supplemental Tool to Drug Pricing System, Continued Discussions Necessary

March 7, 2019
BUSINESS Pfizer Japan Logs 2.6% Growth in FY2018, No Job Cut Planned: Chief

March 6, 2019
TRENDS Drug Makers on Hunt for “Mibyo” Biz Opportunities as Pricing Rules Get Stricter

March 5, 2019
COMMENTARY Generic Makers Shifting to Focus on “Specialty Area” Faced with Tougher Business Environment

March 4, 2019
BUSINESS More Pharmacies Turning to Medical System Network’s Price Negotiation Service after Distribution Guidelines Introduced

March 1, 2019
REGULATORY MHLW to Impose Administrative Fines Only on Misleading Ads, Eyes 4.5% Charge: PMD Law

February 28, 2019
ACADEMIA Investigators Calling Off Trials on First Hyperlactacidemia Drug with No Significant Improvement Shown

February 28, 2019
BUSINESS Nihon Generic Taking Pass on June Listing of Symbicort Copies; 2 Partners Mum

February 27, 2019
BUSINESS Shionogi Specialty Squad Providing Deep Info on Mulpleta/Pirespa, Aims for Higher Sales with Fewer Calls

February 26, 2019

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?

Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…

COMMENTARY

FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed

By Takashi Ebisawa

Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…